These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22576950)

  • 21. Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells.
    Kanagasabai R; Krishnamurthy K; Druhan LJ; Ilangovan G
    J Biol Chem; 2011 Sep; 286(38):33289-300. PubMed ID: 21784846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of proteins responsible for the development of adriamycin resistance in human gastric cancer cells using comparative proteomics analysis.
    Yang YX; Hu HD; Zhang DZ; Ren H
    J Biochem Mol Biol; 2007 Nov; 40(6):853-60. PubMed ID: 18047778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line.
    Guan J; Chen XP; Zhu H; Luo SF; Cao B; Ding L
    World J Gastroenterol; 2004 Dec; 10(23):3522-7. PubMed ID: 15526378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer.
    Shang C; Guo Y; Zhang J; Huang B
    Cancer Chemother Pharmacol; 2016 May; 77(5):1061-7. PubMed ID: 27056384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of adriamycin resistance in human mammary cancer cells by small interfering RNA of MDR1 and MDR3 genes.
    Xiao L; Gao R; Lu S; Ren L; Wang Z
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(6):735-7. PubMed ID: 17357504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of multidrug resistance by ribosomal protein l6 in gastric cancer cells.
    Du J; Shi Y; Pan Y; Jin X; Liu C; Liu N; Han Q; Lu Y; Qiao T; Fan D
    Cancer Biol Ther; 2005 Feb; 4(2):242-7. PubMed ID: 15846068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of 7-
    Chen Y; Li X; Shi L; Ma P; Wang W; Wu N; Gan Y; Han X; Huang S; Kang X; Liu S; Zhen Y
    Aging (Albany NY); 2022 Sep; 14(17):7156-7169. PubMed ID: 36107024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cinnamaldehyde derivative (CB-PIC) sensitizes chemo-resistant cancer cells to drug-induced apoptosis via suppression of MDR1 and its upstream STAT3 and AKT signalling.
    Yun M; Lee D; Park MN; Kim EO; Sohn EJ; Kwon BM; Kim SH
    Cell Physiol Biochem; 2015; 35(5):1821-30. PubMed ID: 25833196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect and mechanisms of TET on human gastric carcinoma cell line SGC7901 and SGC7901/ADR].
    Li Y; Zhao Q; Tan BB; Fan LQ; Liu QW; Jiao ZK; Zhao XF; Hao YJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jan; 34(1):66-70. PubMed ID: 24520791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ZNF139 increases multidrug resistance in gastric cancer cells by inhibiting
    Tan B; Li Y; Zhao Q; Fan L; Wang D
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30126848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of ZNRD1 promotes multidrug-resistant phenotype of gastric cancer cells through upregulation of P-glycoprotein.
    Shi Y; Zhang Y; Zhao Y; Hong L; Liu N; Jin X; Pan Y; Fan D
    Cancer Biol Ther; 2004 Apr; 3(4):377-81. PubMed ID: 14726695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells.
    Guo X; Ma N; Wang J; Song J; Bu X; Cheng Y; Sun K; Xiong H; Jiang G; Zhang B; Wu M; Wei L
    BMC Cancer; 2008 Dec; 8():375. PubMed ID: 19091131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
    Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
    Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of P-glycoprotein-mediated multi-drug resistance by the E3 ubiquitin ligase Cbl-b in human gastric adenocarcinoma cells.
    Zhang Y; Qu X; Hu X; Yang X; Hou K; Teng Y; Zhang J; Sada K; Liu Y
    J Pathol; 2009 Jun; 218(2):248-55. PubMed ID: 19274672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression and significance of prion protein in gastric cancer and multidrug-resistant gastric carcinoma cell line SGC7901/ADR.
    Du J; Pan Y; Shi Y; Guo C; Jin X; Sun L; Liu N; Qiao T; Fan D
    Int J Cancer; 2005 Jan; 113(2):213-20. PubMed ID: 15386405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of GAS1 as an epirubicin resistance-related gene in human gastric cancer cells with a partially randomized small interfering RNA library.
    Zhao L; Pan Y; Gang Y; Wang H; Jin H; Tie J; Xia L; Zhang Y; He L; Yao L; Qiao T; Li T; Liu Z; Fan D
    J Biol Chem; 2009 Sep; 284(39):26273-85. PubMed ID: 19638344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
    Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
    Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
    Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
    Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ribophorin II potentiates P-glycoprotein- and ABCG2-mediated multidrug resistance via activating ERK pathway in gastric cancer.
    Zhang H; Jiang H; Zhang H; Liu J; Hu X; Chen L
    Int J Biol Macromol; 2019 May; 128():574-582. PubMed ID: 30710584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation.
    Kim HG; Hien TT; Han EH; Hwang YP; Choi JH; Kang KW; Kwon KI; Kim BH; Kim SK; Song GY; Jeong TC; Jeong HG
    Br J Pharmacol; 2011 Mar; 162(5):1096-108. PubMed ID: 21054339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.